Education
About Us
Working with TipRanks
Follow Us
Sinopharm Tech Holdings Limited (HK:8156)
:8156
Total Valuation
Sinopharm Tech Holdings Limited has a market cap or net worth of HK$69.07M. The enterprise value is HK$177.91M.
Market CapHK$69.07M
Enterprise ValueHK$177.91M
Share Statistics
Sinopharm Tech Holdings Limited has 633,693,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding633,693,050
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sinopharm Tech Holdings Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.38M
Profits Per Employee-664.80K
Employee Count30
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Sinopharm Tech Holdings Limited is ―. Sinopharm Tech Holdings Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Sinopharm Tech Holdings Limited had revenue of 41.28M and earned -19.70M in profits. Earnings per share was -0.11.
Revenue41.28M
Gross Profit5.02M
Operating Income0.00
Pretax Income-20.33M
Net Income-19.70M
EBITDA4.98M
Earnings Per Share (EPS)-0.11
Cash Flow
In the last 12 months, operating cash flow was -3.94M and capital expenditures 23.00K, giving a free cash flow of -3.91M billion.
Operating Cash Flow-3.94M
Free Cash Flow-3.91M
Free Cash Flow per Share>-0.01
Dividends & Yields
Sinopharm Tech Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change22.22%
50-Day Moving Average0.12
200-Day Moving Average0.10
Relative Strength Index (RSI)44.79
Average Volume (3m)38.77K
Important Dates
Sinopharm Tech Holdings Limited upcoming earnings date is Sep 26, 2025, TBA Not Confirmed.
Last Earnings DateFeb 28, 2025
Next Earnings DateSep 26, 2025
Ex-Dividend Date―
Financial Position
Sinopharm Tech Holdings Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Sinopharm Tech Holdings Limited has paid 83.00K in taxes.
Income Tax83.00K
Effective Tax Rate―
Enterprise Valuation
Sinopharm Tech Holdings Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Sinopharm Tech Holdings Limited has HK$8.51M in cash and marketable securities with HK$0.00 in debt, giving a net cash position of HK$1.50M billion.
Cash & Marketable SecuritiesHK$8.51M
Total DebtHK$0.00
Net CashHK$1.50M
Net Cash Per Share<HK$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Sinopharm Tech Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-11.42%
EPS Growth Forecast26.75%